DAUNOBLASTIN subst sèche 20 mg flac
7680683400019
CH-68340
L01DB02
07.16.1.
1 / 3
google
Details
- Product number
- 6834001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- daunorubicini hydrochloridum 20 mg, mannitolum, pro vitro.
Articles (1)
Daunoblastin 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 50.25
Specialties list
Yes
Generic
No
SL addition date:
01/06/2022
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 68340
- Drug name
- Daunoblastin, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01DB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 04/11/2021
- Authorization expiration date
- 03/11/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAUNOBLASTIN subst sèche 20 mg flac
- Description (DE)
- DAUNOBLASTIN Trockensub 20 mg Durchstf
- Market launch
- 04/11/2021
- Narcotic (BTM)
- No